No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis

被引：0
|
作者：
S. Kastenbauer
B. C. Kieseier
B. F. Becker
机构：
[1] Ludwig–Maximilians–University,Dept. of Neurology
[2] Ludwig–Maximilians–University,Dept. of Physiology
[3] Heinrich–Heine–University,Dept. of Neurology
来源：
Journal of Neurology | 2005年 / 252卷
关键词：
Public Health; Multiple Sclerosis; Oxidative Degradation; Allantoin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：611 / 612
页数：1
相关论文
共 50 条
  • [41] Oxidative modification of blood serum proteins and in multiple sclerosis
    Sadowska-Bartosz, I.
    Adamczyk-Sowa, M.
    Galiniak, S.
    Bartosz, G.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2013, 42 : S197 - S197
  • [42] No evidence of increased genetic susceptibility to autoimmune diseases in Portuguese Multiple Sclerosis patients
    Silva, Ana
    Bettencourt, Andreia
    Santos, Ernestina
    Coutinho, Ester
    Pereira, Clara
    Carvalho, Claudia
    Mendonca, Denisa
    Vasconcelos, Carlos
    Pinho e Costa, Paulo
    Monteiro, Luis
    Martins, Silva Berta
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 254 - 254
  • [43] INCREASED BETA-2-MICROGLOBULIN IN CSF OF MULTIPLE-SCLEROSIS
    ALVAREZCERMENO, JC
    VILLAR, LM
    ROY, G
    FERREIRA, A
    BOOTELLO, A
    GIMENO, A
    GONZALEZPORQUE, P
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (09): : 1238 - 1238
  • [44] CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
    Christensen, Jeppe Romme
    Bornsen, Lars
    Khademi, Mohsen
    Olsson, Tomas
    Jensen, Poul Erik
    Sorensen, Per Soelberg
    Sellebjerg, Finn
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (07) : 877 - 884
  • [45] EVIDENCE FOR A MISSED SIGNAL TO THE CD8(+) CELLS IN CSF OF MULTIPLE-SCLEROSIS PATIENTS
    SARESELLA, M
    GROPE, A
    SPECIALE, L
    MANCUSO, R
    DEBENEDICTIS, R
    CAPUTO, D
    FERRANTE, P
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1995, 16 (07): : 479 - 485
  • [46] Elevated CSF histamine levels in multiple sclerosis patients
    Kallweit U.
    Aritake K.
    Bassetti C.L.
    Blumenthal S.
    Hayaishi O.
    Linnebank M.
    Baumann C.R.
    Urade Y.
    Fluids and Barriers of the CNS, 10 (1)
  • [47] CSF β-amyloid predicts prognosis in patients with multiple sclerosis
    Pietroboni, A. M.
    Carandini, T.
    Colombi, A.
    Caprioli, M.
    Scarioni, M.
    Arighi, A.
    Cioffi, S.
    Oldoni, E.
    Cinnante, C.
    Fenoglio, C.
    Ghezzi, L.
    de Riz, M. A.
    Basilico, P.
    Fumagalli, G. G.
    Triulzi, F.
    Bozzali, M.
    Serra, L.
    Scarpini, E.
    Galimberti, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 325 - 325
  • [48] CSF β-amyloid is not a prognostic marker in multiple sclerosis patients
    Petitfour, Justine
    Ayrignac, Xavier
    Ginestet, Nelly
    Prin, Pauline
    Carra-Dalliere, Clarisse
    Hirtz, Christophe
    Charif, Mahmoud
    Lehmann, Sylvain
    Labauge, Pierre
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [49] Detection of astrocytic autoantibodies in the csf of patients with multiple sclerosis
    Reynolds, A.
    O'Connell, K. E.
    Mok, T.
    Sweeney, B.
    Ryan, A. M.
    Dev, K. K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : 9 - 9
  • [50] Are there indicators of remyelination in blood or CSF of multiple sclerosis patients?
    Massaro, AR
    MULTIPLE SCLEROSIS, 1998, 4 (03): : 228 - 231
12345